Clinical trial
A Single-center Cross-sectional Study to Evaluate the Effectiveness of Antihypertensive Treatment Including Fimasartan and the Dyslipidemia Treatment Including Rosuvastatin and to Assess the Association Between the Two Treatments
NCT02913794 is registered in ClinicalTrials.gov with Boryung Pharmaceutical Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-center Cross-sectional Study to Evaluate the Effectiveness of Antihypertensive Treatment Including Fimasartan and the Dyslipidemia Treatment Including Rosuvastatin and to Assess the Association Between the Two Treatments
- Lead sponsor
- Boryung Pharmaceutical Co., Ltd
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 11, 2016
- Completion date
- March 29, 2018
- Enrollment
- 541 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.